<DOC>
	<DOCNO>NCT00622141</DOCNO>
	<brief_summary>The previous two study generic GPO saquinavir fail prove bioequivalence . In study bio-equivalence investigate healthy Thai volunteer , see whether generic GPO saquinavir show bioequivalence boost Norvir® . If generic formulation bioequivalent subsequent study may follow HIV-1 positive patient .</brief_summary>
	<brief_title>Bioequivalence Study Generic GPO Saquinavir Norvir® Versus Invirase® Norvir®</brief_title>
	<detailed_description>The primary objective establish bioequivalence `` ritonavir boost generic GPO saquinavir '' , Invirase® Norvir® reference drug . The secondary objective evaluate short-term tolerability safety profile generic saquinavir healthy male volunteer .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Written inform consent Healthy male 1845 year old Documented negative test HIV1 infection &lt; 1 wk prior start study risk HIV exposure last 6 month BMI 1825 Normal physical examination Normal CBC , BUN , Cr , AST , ALT , Total bilirubin , evidence active chronic HBV HCV infection History sensitivity/idiosyncrasy drug chemically related compound excipients , may employ study . Relevant history current condition might interfere drug absorption , distribution , metabolism excretion . Inability understand nature extent study procedure require . Participation drug study within 60 day prior first dose . Febrile illness within 3 day first dose . Use concomitant medication Smoke cigarettes 10 cigarette day . Drink alcohol 2 unit day . Discontinue smoke alcohol least 1 month enrollment . Take medication regularly Involvement drug addiction . Heart disease , hypertension , liver disease , kidney disease , GI disease , allergic disease disease may interfere PK study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>ritonavir boost generic GPO saquinavir</keyword>
	<keyword>saftey</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>